Last reviewed · How we verify
NCT06235632
Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers
NA trial testing Policy and Training Intervention in Alcoholic Intoxication in 229 participants. Enrolling by invitation.
1 July 2027
Quick facts
| Lead sponsor | Klein Buendel, Inc. |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 229 |
| Start date | 15 January 2024 |
| Primary completion | 1 July 2027 |
| Estimated completion | 31 August 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Policy and Training Intervention
- Usual and Customary Policy and Training (UC-PT) (Control) Condition
Conditions studied
- Alcoholic Intoxication — all drugs for Alcoholic Intoxication →
- Automobile Accident — all drugs for Automobile Accident →
- Cannabis — all drugs for Cannabis →
Sponsor
Klein Buendel, Inc. — full company profile →
Who can join
21 and older, any sex, with Alcoholic Intoxication or Automobile Accident. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The new recreational marijuana markets are contributing to polysubstance-impaired driving and other harms, especially when marijuana is used in combination with alcohol, by selling marijuana to obviously-intoxicated customers. In this study, the effectiveness of an intervention to reduce the risk of marijuana sales to obviously-intoxicated customers will be tested in the state-licensed recreational marijuana market in Oregon, one of the first states to ban such sales. The intervention will combine efforts by state regulators to increase deterrence of the state law prohibiting marijuana sales to obviously-intoxicated customers with training of store personnel to recognize signs of intoxication and refuse sales. It will also include testing the rate at which visibly intoxicated customers are refused alcohol at nearby establishments that sell alcohol either on-site or off-site
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06235632
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Klein Buendel, Inc. trials
Trials by the same sponsor.
- NCT07417930 — Hybrid Delivery to Increase Access and Sustainability: Evaluating ezParent Implementation · NA · not yet recruiting
- NCT06894277 — Internet-based Talking About Risk and Adolescent Choices: Health and Emotion Regulation Options · NA · recruiting
- NCT05621044 — Physical Activity Smartphone App for African American Men (FitBros) Ph II · NA · completed
- NCT05618158 — Cancer Prevention for Young Rural Adults · NA · completed
- NCT05774600 — Virtual Sun Safe Workplaces Ph II (SSW Works) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06235632 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Klein Buendel, Inc.
- Last refreshed: 5 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06235632.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing